Blood from human umbilical cords is a rich source of hematopoeitic stem cells, the progenitors that can reconstitute all of the different cell types in our blood, including oxygen-carrying red blood cells and white blood cells that are our major defense against infections. Cord blood contains a higher percentage of stem cells than adult bone marrow (another source of blood stem cells), and has several additional advantages: cord blood stem cells divide faster than stem cells from bone marrow and have longer telomeres. In addition, cord blood contains fewer immune cells, and those present have not yet undergone the extensive education process that allows them to distinguish between self and non-self. This is important in the context of transplantation, where host cells can attack donor cells and vice versa (a process known as graft-versus-host disease that is responsible for many deaths after bone marrow transplantation).
One obstacle to using cord blood more routinely as a source of stem cells in transplantation patients is the amount of blood required. Clinical trials have established that higher numbers of blood cells per kilogram of body weight of the recipient are associated with improved transplantation outcome. However, the amount of blood cells collected from cords is often not sufficient for an adult recipient. Scientists have therefore attempted to culture and expand cord blood-derived cells before transplanting them into patients. As they report in the October 21 issue of the Journal of Clinical Investigation, Irwin Bernstein and colleagues (Fred Hutchinson Cancer Center, Seattle, and University of Washington, Seattle), have been successful in doing so. Exposing human cord blood to a particular molecule called Delta-1 under defined culture conditions resulted in an over 100-fold increase in the number of the most immature stem cells. Other progenitors that maintained the potential to differentiate into multiple different blood cell types were also expanded.
When the scientists harvested the cells after the expansion and transplanted them into immuno-deficient mice (who in many ways resemble leukemia patients who have undergone radiation treatment prior to a bone-marrow transplant), they found that the cultured cells were more potent in reconstituting the recipients blood and immune cell systems that non-cultured cells or those cultured in the absence of Delta-1.
Brooke Grindlinger, PhD | EurekAlert!
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering